semaglutide negative effects of on bone in obese mice Comparative safety and side effects

While tirzepatide degradation typically results in loss of activity rather than formation of toxic compounds, the safety profile of degraded peptide products has not been systematically studied in humans

Semaglutide is a large and fragile molecule (a peptide), so getting it into the bloodstream from the stomach is a real challenge

Additionally, Semaglutide offers extra health benefits such as improvements in cardiovascular risk factors and blood sugar levels

Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss